SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
572Biogen to Evaluate GlycoFi's Protein Production Platform Monday November 10,nigel bates-11/10/2003
571Progenics and Cytogen Report New Findings on Prostate Cancer Therapies Monday NoIcebrg-11/10/2003
570Discerna Ltd. <i>When Xenova acquired KS Biomedix, they got 50% of Discernigel bates-11/6/2003
569NovImmune’s pipeline for Therapeutic Monoclonal Antibodies Pipeline DevelopmentIcebrg-11/4/2003
568NovImmune is a Medarex collaborator. Erik <i>PRINCETON, N.J. and GENEVA, Icebrg-11/4/2003
567Miikana Therapeutics and NovImmune SA Sign Strategic Alliance for Antibody Develnigel bates-11/4/2003
566For those of us who once thought that antibodies might be a quick and easy routenigel bates-11/4/2003
565THE PRODUCTION OF RECOMBINANT PHARMACEUTICAL PROTEINS IN PLANTS Julian K-C. Ma1Icebrg-10/31/2003
564Morphotek Announces Contract Manufacturing and Development Collaboration Agreemenigel bates-10/20/2003
563Interesting. Might be worth checking these out: <i>As a result, Borean Phnigel bates-10/13/2003
562Borean Pharma Accomplishes Major Technological Achievement Monday October 13, 2:Icebrg-10/13/2003
561Who's Got Game in Antibody Development? [This has been kind of a slow placeIcebrg-10/3/2003
560Modified yeast produces fully human proteins 12:45 29 August 03 [Some more publIcebrg-8/31/2003
559Affimed and Dyax Cross-License Antibody Technologies HEIDELBERG, Germany and CAnigel bates-8/13/2003
558(Aug 1 2003) MorphoSys: 3rd Milestone in Centocor Collaboration MorphoSys AG (Fnigel bates-8/4/2003
557ImmunoGen, Inc. and Aventis Sign Collaboration Agreement to Discover, Develop, aGary Mohilner-7/31/2003
556Ron Garren focuses on antibody programs: biospace.com Cheers, Tucktuck-7/18/2003
555Diversa's Human Antibody Program Recognized With The Gold Innovations in Heanigel bates-6/27/2003
554Erik, I'm sure DNA's patent position (and cozy relationship w/PDLI) deJFitnich-6/26/2003
553Anti-CD20 There seems to be a strong interest to develop a Rituximab Mk II. JusIcebrg-6/26/2003
552From my POV, this is simply what genz first promised years ago. GENZ is very tokeokalani'nui-6/24/2003
551Some validation for DYAX, as Genzyme take them seriously - Message 19056685 &lnigel bates-6/24/2003
550Garren's website is at www.biotechinsight.com He publishes articles periodiJMarcus-6/23/2003
549I own these 3 too. Who is Dr. Garren? Is he any good at this?Madharry-6/23/2003
548>>MONTREAL--(BUSINESS WIRE)--June 23, 2003--MDS Pharma Services, a leadingtuck-6/23/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News